STOCK TITAN

Arcutis CEO Todd Watanabe gifts 144,232 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Arcutis Biotherapeutics, Inc. President and CEO Todd Watanabe reported that the TFW-NH 2026 Trust received 144,232 common shares as a gift on November 13, 2026. Watanabe reported 568,594 shares following the transfer; the trust’s securities are not reported as beneficially owned by him.

Insider Watanabe Todd
Role See Remarks
Type Security Shares Price Value
Gift Common Stock F1 144,232 $0.00 $0.00
Holdings After Transaction: Common Stock — 568,594 shares (Direct)
Footnotes (1)
  1. F1. Represents a gift by the Reporting Person to the TFW-NH 2026 Trust, an irrevocable trust of which IQ-EQ Trust Company, U.S., LLC serves as trustee. The Reporting Person is not a trustee of the trust, does not have investment control over the trust securities, and does not have power to revoke the trust. Accordingly, the securities held by the trust are not reported as beneficially owned by the Reporting Person.
Gift transfer 144,232 shares Arcutis common stock gifted to the TFW-NH 2026 Trust on November 13, 2026
Shares following transaction 568,594 shares Watanabe’s reported direct holdings following the November 13, 2026 gift
beneficially owned regulatory
"not reported as beneficially owned by the Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ARQT shares did the TFW-NH 2026 Trust receive?

The TFW-NH 2026 Trust received 144,232 shares of Arcutis common stock as a gift from President and CEO Todd Watanabe on November 13, 2026. IQ-EQ Trust Company, U.S., LLC serves as trustee of the irrevocable trust.

How many ARQT shares did Todd Watanabe report after the gift?

Todd Watanabe reported direct holdings of 568,594 Arcutis shares after the gift. He has no investment control over securities held by the trust and no power to revoke it; those trust shares are not reported as beneficially owned by him.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Watanabe Todd

(Last)(First)(Middle)
C/O ARCUTIS BIOTHERAPEUTICS, INC.
3027 TOWNSGATE ROAD, SUITE 300

(Street)
WESTLAKE VILLAGE CALIFORNIA 91361

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Arcutis Biotherapeutics, Inc. [ ARQT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/13/2026G144,232(1)D$0568,594D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a gift by the Reporting Person to the TFW-NH 2026 Trust, an irrevocable trust of which IQ-EQ Trust Company, U.S., LLC serves as trustee. The Reporting Person is not a trustee of the trust, does not have investment control over the trust securities, and does not have power to revoke the trust. Accordingly, the securities held by the trust are not reported as beneficially owned by the Reporting Person.
Remarks:
Reporting Person's title: President and Chief Executive Officer
/s/ Latha Vairavan, as Attorney-in-Fact for Todd Watanabe11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading